Related Experiment Video
Updated: May 17, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Genetic Susceptibility to Fungal Infections in Humans
1Clinical Mycology Unit, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland, USA.
Abstract:
Most fungal infections in humans occur in the setting of iatrogenic immunosuppression or HIV infection. In the absence of these factors, fungi cause mild, self-limited infections that typically involve mucocutaneous surfaces. Hence, when persistent or recurrent mucocutaneous infections (chronic mucocutaneous candidiasis [CMC]) or invasive fungal infections (IFIs) develop in a "normal" host, they are indicative of genetic defects causing innate or adaptive immune dysfunction. In this review, recent developments concerning genetic and immunologic factors that affect the risk for IFIs and CMC are critically discussed.
Insights
Genetic defects in immune function can lead to severe fungal infections like chronic mucocutaneous candidiasis (CMC) and invasive fungal infections (IFIs) in otherwise healthy individuals. This review explores recent findings on these genetic and immunologic factors.
Area of Science:
- Immunology
- Genetics
- Mycology
Background:
- Fungal infections typically occur in immunocompromised individuals (e.g., HIV, iatrogenic immunosuppression).
- In healthy hosts, fungi usually cause mild, self-limiting mucocutaneous infections.
- Persistent or invasive fungal infections in healthy individuals suggest underlying immune dysfunction.
Purpose of the Study:
- To review recent advancements in understanding genetic and immunologic factors influencing fungal infection risk.
- To critically discuss the role of innate and adaptive immune dysfunction in chronic mucocutaneous candidiasis (CMC) and invasive fungal infections (IFIs).
Main Methods:
- Literature review of recent developments in genetics and immunology related to fungal infections.
- Critical analysis of studies investigating genetic defects and immune dysfunction.
Main Results:
- Identified genetic defects as a key cause of susceptibility to fungal infections in non-immunocompromised hosts.
- Highlighted the link between specific immune dysfunctions and the development of CMC and IFIs.
- Discussed recent findings on the interplay of genetic and immunologic factors.
Conclusions:
- Genetic defects leading to innate or adaptive immune dysfunction are critical in the pathogenesis of CMC and IFIs in "normal" hosts.
- Further research into these genetic and immunologic factors is essential for understanding and managing fungal infections.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Fungal Phylum Microsporidia
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Drug toxicity: Idiosyncratic Reactions
Principles of Pharmacogenetics: Types of Genetic Variants
Fungal Phylum Ascomycota

